Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: A nested case-control study using the GPRD

Vaccine

Volumn 31, Issue 12, 2013, Pages 1590-1596

  Hak, Eelko ^a   Shea, Kimberly M ^b   Jick, Susan S ^b,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c Boston Collaborative Drug Surveillance Program   (United States)

Author keywords

Case control; Conjugate pneumococcal vaccine; Epidemiology; General practice; Immunization; Infant

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; GENERAL PRACTICE; HUMAN; INCIDENCE; INFANT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK; STREPTOCOCCUS PNEUMONIA; UNITED KINGDOM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MOTHERS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; VACCINATION; YOUNG ADULT;

EID: 84875233223     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.018     Document Type: Article

References (26)

1. Health Protection Agency. Invasive pneumococcal disease (IPD) in England and Wales after 7-valent conjugate vaccine (PCV7): potential impact of 10- and 13-valent vaccine. [accessed 01.07.12]. http://www.hpa.org.uk/web/HPAwebfile/HPAweb_C/1245581527892.
2. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
3. CDC Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54:893-897.
4. Gladstone R.A., Jefferies J.M., Faust S.N., Clarke S.C. Continued control of pneumococcal disease in the UK - the impact of vaccination. J Med Microbiol 2011, 60:1-8.
5. Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:780-786.
6. Andrews N., Waight P.A., Borrow R., Ladhani S., George R.C., Slack M.P., et al. Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales. PLoS One 2011, 6:e28435. [Epub ahead of print 2011 December 2].
7. Hammitt L.L., Bruden D.L., Butler J.C., Baggett H.C., Hurlburt D.A., Reasonover A., et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 2006, 193(June (11)):1487-1494.
8. van Gils E.J.M., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., et al. Effect of reduced dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage in children: a randomized controlled trial. JAMA 2009, 302:159-167.
9. Flasche S., Van Hoek A.J., Sheasby E., Waight P., Andrews N., Sheppard S., et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLOS Med 2011, 8:1-9.
10. Rodenburg G.D., de Greeff S.C., Jansen A.G., de Melker H.E., Schouls L.M., Hak E., et al. Effects of pneumococcal conjugate vaccine 2 years after its introduction, The Netherlands. Emerg Infect Dis 2010, 16:816-823.
11. Metlay J.P., Lautenbach E., Li Y., Shults J., Edelestein P.H. The changing role of exposure to children as a risk factor for bacteremic pneumococcal disease in the post conjugate area. Arch Intern Med 2010, 170:725-731.
12. Elston J.W., Santaniello-Newton A., Meigh J.A., Harmer D., Allgar V., Allison T., et al. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009. Epidemiol Infect 2011, 1:1-15.
13. Jick H., Jick S.S., Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991, 302:766-768.
14. Jick H., Terris B.Z., Derby L.E., Jick S.S. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992, 1:347-349.
15. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., Garcia Rodríguez L.A., Ruigómez A., Meier C.R., et al. Validity of the general practice research database. Pharmacotherapy 2003, 23:686-689.
16. Schlienger R.G., Fedson D.S., Jick S.S., Jick H., Meier C.R. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007, 325-332.
17. Jick H., Hagberg K.W. Effectiveness of influenza vaccination in the United kingdom, 1996-2007. Pharmacotherapy 2010, 30:1199-1206.
18. Jick H., Hagberg K.W. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines. Vaccine 2010, 28:4588-4592.
19. Jick H., Chamberlin D.P., Hagberg K.W. The origin and spread of a mumps epidemic: United Kingdom, 2003-2006. Epidemiology 2009, 20:656-661.
20. Shankar A., Samraj R., Aiyedun V., Janda M., Ramaiah S. General practitioners' perceptions on pneumococcal vaccination for children in United Kingdom. Hum Vaccine 2009, 5:177-180.
21. Vinogradova Y., Hippisley-Cox J., Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009, 59:e329-e338.
22. Hak E., Bont J., Hoes A.W., Verheij T.J. Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam Pract 2005, 22:375-380.
23. Ardanuy C., Tubau F., Pallares R., Calatayud L., Dominquez M.A., Rolo D., et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 2009, 48:57-64.
24. Jansen A.G., Rodenburg G.D., van der Ende A., van Alphen L., Veenhoven R.H., Spanjaard L., et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009, 49(July (2)):e23-e29.
25. NHS. NHS Immunisation Statistics England 2009-2010. The Health and Social Care Information Centre, Public health Indicators and Population Statistics Team; 2010.
26. Amar R.K., Jick S.S., Rosenberg D., Maher T.M., Meier C.R. Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. Respiration 2012, 84(3):200-206.